Asish Saha

Asish Saha has a long history of experience in the medical and scientific fields. Asish began working in 2005 as an Associate Professor at Boston University School of Medicine, where they were a faculty member and research investigator with a focus on how disorders of fuel metabolism cause disease. In 2010, they began working as a Collaborator and Consultant at Nimbus Therapeutics, where they applied their expertise in drug discovery and development. In 2018, they began working at ZoneLabs, Inc., first as the Chief Scientific Director and then as the Director of Research and Development. At ZoneLabs, they were responsible for leading the development and sales of innovative, patented nutraceutical products. Asish also conducted studies on the beneficial effects of exercise in insulin resistant humans.

Asish Saha holds a Ph.D. in Biochemistry from Calcutta University, Kolkata and has completed a Post-doctoral Fellowship at the University of Pittsburgh School of Medicine, where they conducted research.